Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Infuserve America is a leading specialty and compounding pharmacy based in St. Petersburg, Florida, specializing in intravenous (IV) therapies and complex medication management. Founded in 1992, the company provides high-quality compounded sterile preparations for patients with chronic and rare conditions, including Lyme disease, primary immunodeficiencies, and nutritional disorders. Infuserve America operates as both a 503A pharmacy and a 503B outsourcing facility, ensuring compliance with rigorous safety and quality standards for both individual patient prescriptions and office-use medications. Their services extend to home infusion support, offering a comprehensive approach to patient care through specialized clinical monitoring and delivery. The company is particularly recognized for its expertise in providing customized IV antibiotic protocols and nutritional support for complex infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Infuserve America.